We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Digital Health Interventions Reduce Risk of Cardiovascular Disease

By HospiMedica International staff writers
Posted on 18 May 2015
Digital health interventions (DHIs), such as telemedicine and text message reminders, reduce the relative risk of cardiovascular disease (CVD) by 40%, according to a new study.

Researchers at the Mayo Clinic (Rochester, MN, USA) conducted a systematic search of PubMed, MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, and other sources for articles that examined elements of DHI and CVD outcomes or risk factors. More...
The authors extracted CVD outcomes and data on risk factors for CVD such as weight, body mass index (BMI), blood pressure (BP), and lipid levels from 51 full-text articles that met validity and inclusion criteria.

The results showed that DHI significantly reduced CVD outcomes. Web-based strategies, email, mobile phones, mobile applications, text messaging, and monitoring sensors reduced the absolute risk of CVD by about 7%, more than use of statins, aspirin, or anti-hypertension drugs. Concomitant reductions were seen in weight and BMI, but not blood pressure. They found that some DHIs are more effective than others, with internet-based modalities, text messages, and telemedicine lowering risk more than emails and data monitoring. The study was published in the April 2015 issue of Mayo Clinic Proceedings.

“Because DHI use does not directly reduce CVD risk, these observed benefits likely reflect increased adherence to evidence-based preventive therapies such as statins, aspirin, or β-blockers,” concluded lead author R. Jay Widmer, MD, PhD, and colleagues of the division of cardiovascular diseases. “DHIs tend to trigger behavioral changes, while drugs treat the condition directly. A combination of the two could be optimal.”

“With nearly 50,000 health care–related apps now available for download and numerous internet-based digital health intervention solutions available, the benefit of digital health interventions on cardiovascular disease prevention and outcomes, both primary and secondary, merits reexamination,” suggested the authors.

Related Links:

Mayo Clinic



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.